Skip to main content
NCBI home page
Heart logoLink to Heart
. 2002 Oct;88(Suppl 2):ii5–ii8. doi: 10.1136/heart.88.suppl_2.ii5

Contemporary management of heart failure in clinical practice

J Cleland
PMCID: PMC1876266  PMID: 12213792

Full Text

The Full Text of this article is available as a PDF (117.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown A. M., Cleland J. G. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J. 1998 Jul;19(7):1063–1069. [PubMed] [Google Scholar]
  2. Clark A. L., Coats A. J. Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. BMJ. 1995 Apr 15;310(6985):973–974. doi: 10.1136/bmj.310.6985.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke K. W., Gray D., Hampton J. R. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994 Jun;71(6):584–587. doi: 10.1136/hrt.71.6.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G. ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'? J Hum Hypertens. 1995 Jun;9(6):435–442. [PubMed] [Google Scholar]
  5. Cleland J. G., Alamgir F., Nikitin N. P., Clark A. L., Norell M. What is the optimal medical management of ischemic heart failure? Prog Cardiovasc Dis. 2001 Mar-Apr;43(5):433–455. doi: 10.1053/pcad.2001.20670. [DOI] [PubMed] [Google Scholar]
  6. Cleland J. G. Anticoagulant and antiplatelet therapy in heart failure. Curr Opin Cardiol. 1997 May;12(3):276–287. doi: 10.1097/00001573-199705000-00009. [DOI] [PubMed] [Google Scholar]
  7. Cleland J. G., Armstrong P., Horowitz J. D., Massie B., Packer M., Poole-Wilson P. A., Rydén L. Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study. Eur J Heart Fail. 1999 Mar;1(1):73–79. doi: 10.1016/S1388-9842(98)00002-6. [DOI] [PubMed] [Google Scholar]
  8. Cleland J. G., Khand A., Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J. 2001 Apr;22(8):623–626. doi: 10.1053/euhj.2000.2493. [DOI] [PubMed] [Google Scholar]
  9. Cleland J. G., Swedberg K., Cohen-Solal A., Cosin-Aguilar J., Dietz R., Follath F., Gavazzi A., Hobbs R., Korewicki J., Madeira H. C. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail. 2000 Jun;2(2):123–132. doi: 10.1016/s1388-9842(00)00081-7. [DOI] [PubMed] [Google Scholar]
  10. Cohn J. N., Tognoni G., Glazer R. D., Spormann D., Hester A. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail. 1999 Jun;5(2):155–160. doi: 10.1016/s1071-9164(99)90038-6. [DOI] [PubMed] [Google Scholar]
  11. Cowie M. R., Wood D. A., Coats A. J., Thompson S. G., Poole-Wilson P. A., Suresh V., Sutton G. C. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999 Mar;20(6):421–428. doi: 10.1053/euhj.1998.1280. [DOI] [PubMed] [Google Scholar]
  12. Davie A. P., McMurray J. J. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad Med J. 1999 Apr;75(882):219–212. doi: 10.1136/pgmj.75.882.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Davies M., Hobbs F., Davis R., Kenkre J., Roalfe A. K., Hare R., Wosornu D., Lancashire R. J. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001 Aug 11;358(9280):439–444. doi: 10.1016/s0140-6736(01)05620-3. [DOI] [PubMed] [Google Scholar]
  14. Erdmann E., Lechat P., Verkenne P., Wiemann H. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail. 2001 Aug;3(4):469–479. doi: 10.1016/s1388-9842(01)00174-x. [DOI] [PubMed] [Google Scholar]
  15. Fryback D. G., Dasbach E. J., Klein R., Klein B. E., Dorn N., Peterson K., Martin P. A. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993 Apr-Jun;13(2):89–102. doi: 10.1177/0272989X9301300202. [DOI] [PubMed] [Google Scholar]
  16. Ghali J. K., Kadakia S., Cooper R., Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med. 1988 Sep;148(9):2013–2016. [PubMed] [Google Scholar]
  17. Gooding J., Jette A. M. Hospital readmissions among the elderly. J Am Geriatr Soc. 1985 Sep;33(9):595–601. doi: 10.1111/j.1532-5415.1985.tb06315.x. [DOI] [PubMed] [Google Scholar]
  18. Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. Eur Heart J. 1995 Jun;16(6):741–751. [PubMed] [Google Scholar]
  19. Hillis G. S., Trent R. J., Winton P., MacLeod A. M., Jennings K. P. Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? QJM. 1996 Feb;89(2):145–150. doi: 10.1093/qjmed/89.2.145. [DOI] [PubMed] [Google Scholar]
  20. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., El Allaf D., Vítovec J., Aldershvile J. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000 Mar 8;283(10):1295–1302. doi: 10.1001/jama.283.10.1295. [DOI] [PubMed] [Google Scholar]
  21. Khand A. U., Gemmell I., Rankin A. C., Cleland J. G. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J. 2001 Jan;22(2):153–164. doi: 10.1053/euhj.2000.2175. [DOI] [PubMed] [Google Scholar]
  22. Khand A., Gemmel I., Clark A. L., Cleland J. G. Is the prognosis of heart failure improving? J Am Coll Cardiol. 2000 Dec;36(7):2284–2286. doi: 10.1016/s0735-1097(00)00995-5. [DOI] [PubMed] [Google Scholar]
  23. Mair F. S., Crowley T. S., Bundred P. E. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract. 1996 Feb;46(403):77–79. [PMC free article] [PubMed] [Google Scholar]
  24. Massie B. M., Shah N. B. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997 Jun;133(6):703–712. doi: 10.1016/s0002-8703(97)70173-x. [DOI] [PubMed] [Google Scholar]
  25. McDonagh T. A., Morrison C. E., Lawrence A., Ford I., Tunstall-Pedoe H., McMurray J. J., Dargie H. J. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997 Sep 20;350(9081):829–833. doi: 10.1016/S0140-6736(97)03033-X. [DOI] [PubMed] [Google Scholar]
  26. McMurray J., McDonagh T., Morrison C. E., Dargie H. J. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993 Sep;14(9):1158–1162. doi: 10.1093/eurheartj/14.9.1158. [DOI] [PubMed] [Google Scholar]
  27. Monane M., Bohn R. L., Gurwitz J. H., Glynn R. J., Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994 Feb 28;154(4):433–437. [PubMed] [Google Scholar]
  28. Mosterd A., Cost B., Hoes A. W., de Bruijne M. C., Deckers J. W., Hofman A., Grobbee D. E. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001 Aug;22(15):1318–1327. doi: 10.1053/euhj.2000.2533. [DOI] [PubMed] [Google Scholar]
  29. Mosterd A., Hoes A. W., de Bruyne M. C., Deckers J. W., Linker D. T., Hofman A., Grobbee D. E. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 1999 Mar;20(6):447–455. [PubMed] [Google Scholar]
  30. Packer M., Coats A. J., Fowler M. B., Katus H. A., Krum H., Mohacsi P., Rouleau J. L., Tendera M., Castaigne A., Roecker E. B. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001 May 31;344(22):1651–1658. doi: 10.1056/NEJM200105313442201. [DOI] [PubMed] [Google Scholar]
  31. Parameshwar J., Poole-Wilson P. A., Sutton G. C. Heart failure in a district general hospital. J R Coll Physicians Lond. 1992 Apr;26(2):139–142. [PMC free article] [PubMed] [Google Scholar]
  32. Philbin E. F., Andreaou C., Rocco T. A., Lynch L. J., Baker S. L. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996 Apr 15;77(10):832–838. doi: 10.1016/s0002-9149(97)89177-1. [DOI] [PubMed] [Google Scholar]
  33. Philbin E. F. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol. 1998 Feb;21(2):103–108. doi: 10.1002/clc.4960210208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 Sep 2;341(10):709–717. doi: 10.1056/NEJM199909023411001. [DOI] [PubMed] [Google Scholar]
  35. Remes J., Länsimies E., Pyörälä K. Usefulness of M-mode echocardiography in the diagnosis of heart failure. Cardiology. 1991;78(3):267–277. doi: 10.1159/000174793. [DOI] [PubMed] [Google Scholar]
  36. Remes J., Miettinen H., Reunanen A., Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991 Mar;12(3):315–321. doi: 10.1093/oxfordjournals.eurheartj.a059896. [DOI] [PubMed] [Google Scholar]
  37. Rich M. W., Beckham V., Wittenberg C., Leven C. L., Freedland K. E., Carney R. M. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995 Nov 2;333(18):1190–1195. doi: 10.1056/NEJM199511023331806. [DOI] [PubMed] [Google Scholar]
  38. Stewart A. L., Greenfield S., Hays R. D., Wells K., Rogers W. H., Berry S. D., McGlynn E. A., Ware J. E., Jr Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989 Aug 18;262(7):907–913. [PubMed] [Google Scholar]
  39. Stewart S., MacIntyre K., Hole D. J., Capewell S., McMurray J. J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001 Jun;3(3):315–322. doi: 10.1016/s1388-9842(00)00141-0. [DOI] [PubMed] [Google Scholar]
  40. Vaz F. G., Seymour D. G. A prospective study of elderly general surgical patients: I. Pre-operative medical problems. Age Ageing. 1989 Sep;18(5):309–315. doi: 10.1093/ageing/18.5.309. [DOI] [PubMed] [Google Scholar]
  41. Wheeldon N. M., MacDonald T. M., Flucker C. J., McKendrick A. D., McDevitt D. G., Struthers A. D. Echocardiography in chronic heart failure in the community. Q J Med. 1993 Jan;86(1):17–23. [PubMed] [Google Scholar]
  42. Witte K., Thackray S., Clark A. L., Cooklin M., Cleland J. G. Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART. Eur J Heart Fail. 2000 Dec;2(4):455–460. doi: 10.1016/s1388-9842(00)00127-6. [DOI] [PubMed] [Google Scholar]
  43. Wolinsky F. D., Smith D. M., Stump T. E., Overhage J. M., Lubitz R. M. The sequelae of hospitalization for congestive heart failure among older adults. J Am Geriatr Soc. 1997 May;45(5):558–563. doi: 10.1111/j.1532-5415.1997.tb03087.x. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES